Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Huntington Bancshares Incorporated to Present at the UBS Financial Services Conference
-
RADIANT LOGISTICS TO HOST INVESTOR CALL TO DISCUSS FINANCIAL RESULTS FOR SECOND FISCAL QUARTER ENDED DECEMBER 31, 2024
-
Jack Henry & Associates, Inc. Reports Second Quarter Fiscal 2025 Results
-
Carlisle Companies Reports Fourth Quarter Results
-
FMC Corporation announces 2024 fourth quarter and full year results, provides 2025 outlook
-
The AZEK Company Announces First Quarter Fiscal 2025 Results; Raises Full-Year Fiscal 2025 Net Sales and Adjusted EBITDA Outlook
-
Mattel Reports Fourth Quarter and Full Year 2024 Financial Results
-
CCC Intelligent Solutions Announces Date of Fourth Quarter 2024 Earnings Call
-
Columbia Sportswear Company Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Full Year 2025 Financial Outlook
-
Aviat Networks Announces Fiscal 2025 Second Quarter and Six Month Financial Results
-
8x8, Inc. Announces Third Quarter Fiscal Year 2025 Financial Results
-
H&R Block Reports Fiscal 2025 Second Quarter Results
-
Ichor Holdings, Ltd. Announces Fourth Quarter and Fiscal Year 2024 Financial Results
-
Aspen Technology Announces Financial Results for the Second Quarter of Fiscal 2025
-
Kulicke & Soffa Reports First Quarter 2025 Results
-
Trinity Capital Inc. Announces Preliminary Estimates of Financial Results for Fourth Quarter and Year Ended 2024
-
Simon® Reports Fourth Quarter and Full Year 2024 Results
-
Oscar Health Announces Fourth Quarter and Full Year 2024 Results; Introduces Full Year 2025 Outlook
-
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Optimal Blue Introduces Seven Major Innovations at Its Inaugural User Summit in San Diego
-
Q32 Bio to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference
-
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Neutrogena® Introduces Tate McRae as Global Brand Ambassador
-
QIAGEN receives positive court decision reaffirming an important QuantiFERON-TB patent
-
Quince Therapeutics Receives Notice of Allowance Covering Innovative Method of Use for Lead Indication Ataxia-Telangiectasia
-
Olo Announces Date of Fourth Quarter and Fiscal Year 2024 Earnings Call
-
Nuvectis Pharma Announces Proposed Public Offering of Common Stock
-
Exagen Inc. to Participate in Upcoming Investor Conferences
-
Nasdaq Reports January 2025 Volumes
-
Varonis Announces Fourth Quarter 2024 and Full-Year 2024 Financial Results
-
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024
-
ASGN Incorporated to Acquire TopBloc, A Preferred Workday Services Partner
-
Carbon Revolution Announces Receipt of Extension from Nasdaq Stock Market
-
Runway Growth Finance Corp. Announces Date for Fourth Quarter and Full Year 2024 Financial Results and Conference Call
-
InnovAge Announces Financial Results For the Fiscal Second Quarter Ended December 31, 2024
-
Dynagas LNG Partners LP Declares Cash Distribution on its Series B Preferred Units
-
Nasdaq CEO Adena Friedman to Present at the 2025 UBS Financial Services Conference
-
Intapp Announces Second Quarter Fiscal Year 2025 Financial Results
-
Golden Entertainment to Report 2024 Fourth Quarter and Full Year Results on February 27 and Host Conference Call and Webcast
-
CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Latham Group, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release and Conference Call Date
-
AdaptHealth Corp. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call
-
HF Foods Group Inc. to Participate in the Oppenheimer Emerging Growth Conference
-
Ambassador David Pressman Returns to Jenner & Block
-
Omnicom Reports Fourth Quarter and Full Year 2024 Results
-
Husqvarna and Flex announce strategic partnership
-
Horizon Space Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing on February 5, 2025
-
Amdocs Limited Reports First Quarter Fiscal 2025 Results
-
NVO INVESTOR ALERT: Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
